Weekly STERIS plc (NYSE:STE) Ratings as of Jun 27, 2018

June 27, 2018 - By Bridget Boland

STERIS plc (NYSE:STE) Corporate Logo
During Q1 2018 the big money sentiment increased to 0.33. That’s change of 0.16, from 2017Q4’s 0.17. 2 investors sold all, 1 reduced holdings as STERIS plc ratio improved. 0 rose stakes while 1 funds acquired stakes. Funds hold 21,503 shares thus 9.44% more from 2017Q4’s 19,649 shares.
Illinois-based Prudential Plc has invested 0% in STERIS plc (NYSE:STE). Alphamark Advsr Limited holds 0.01% of its capital in STERIS plc (NYSE:STE) for 150 shs. Eqis Cap Mgmt reported 4,277 shs. Fruth Investment stated it has 0.55% in STERIS plc (NYSE:STE).

STERIS plc (NYSE:STE) Ratings Coverage

A total of 3 analysts rate STERIS (NYSE:STE) as follows: 2 “Buy”, 1 “Hold” and 0 “Sell”. Тherefore 67% are bullish. (NYSE:STE) has 3 ratings reports on Jun 27, 2018 according to StockzIntelligence. On Thursday, February 8 the stock of STERIS plc (NYSE:STE) has “Buy” rating given by KeyBanc Capital Markets. In Thursday, February 8 report Northcoast maintained the stock with “Buy” rating. On Wednesday, January 3 Raymond James downgraded STERIS plc (NYSE:STE) to “Market Perform” rating. Listed here are STERIS plc (NYSE:STE) PTs and latest ratings.

08/02/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $103.0 Maintain
08/02/2018 Broker: Northcoast Rating: Buy New Target: $102.0 Maintain
03/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $100 Downgrade

Ticker’s shares touched $105.09 during the last trading session after 0.32% change.STERIS plc has volume of 316,343 shares. Since June 27, 2017 STE has risen 34.02% and is uptrending. The stock outperformed the S&P 500 by 21.45%.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide.The firm is worth $8.89 billion. The companyÂ’s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.The P/E ratio is 37.02. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

There’s a significant STERIS plc (NYSE:STE) news brought out by Globenewswire.com. It’s a report titled: “Research Report Identifies STERIS plc, Parker-Hannifin, Sturm, Ruger, CoBiz Financial, Black Hills, and Glacier with …” on June 22, 2018.

STERIS plc (NYSE:STE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.